相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effects of methanolic extract of Glycyrrhiza glabra on the prevention and treatment of bleomycin-induced pulmonary fibrosis in rat: experimental study
Mitra Samareh Fekri et al.
DRUG AND CHEMICAL TOXICOLOGY (2021)
Salidroside Ameliorates Renal Interstitial Fibrosis by Inhibiting the TLR4/NF-B and MAPK Signaling Pathways
Rui Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway
Li Jia et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
Serological Assessment of Activated Fibroblasts by alpha-Smooth Muscle Actin (α-SMA): A Noninvasive Biomarker of Activated Fibroblasts in Lung Disorders
Signe Holm Nielsen et al.
TRANSLATIONAL ONCOLOGY (2019)
Activation of Nicotinic Acetylcholine α7 Receptor Attenuates Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Downregulating the NLRP3 Inflammasome
Yan Deng et al.
FRONTIERS IN PHARMACOLOGY (2019)
The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis
Meritxell Tort Tarres et al.
THORAX (2019)
Baishouwu Extract Suppresses the Development of Hepatocellular Carcinoma via TLR4/MyD88/NF-κB Pathway
Yong-fang Ding et al.
FRONTIERS IN PHARMACOLOGY (2019)
Human epididymis protein 4 (HE4) protects against cystic pulmonary fibrosis associated-inflammation through inhibition of NF-κB and MAPK singnaling
Jinli Wang et al.
GENES & GENOMICS (2019)
Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways
Yuting Zhang et al.
PHARMACOLOGICAL RESEARCH (2019)
Effect of Kangxianling Decoction on Expression of TGF-1/Smads and Extracellular Matrix Deposition
Jing Ji et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Inflammation and fibrosis
Matthias Mack
MATRIX BIOLOGY (2018)
Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways
Zheng Pang et al.
PLOS ONE (2018)
NLRP3 inflammasome activation and lung fibrosis caused by airborne fine particulate matter
Runxiao Zheng et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2018)
Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis
Swati Bhattacharyya et al.
FRONTIERS IN IMMUNOLOGY (2018)
Differential effects of innate immune variants of surfactant protein-A1 (SFTPA1) and SP-A2 (SFTPA2) in airway function after Klebsiella pneumoniae infection and sex differences
Nithyananda Thorenoor et al.
RESPIRATORY RESEARCH (2018)
NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis
Rui Tian et al.
EXPERIMENTAL CELL RESEARCH (2017)
Danggui Buxue Tang (Astragali Radix and Angelicae Sinensis Radix) for menopausal symptoms: A review
Huang Q. Lin et al.
JOURNAL OF ETHNOPHARMACOLOGY (2017)
Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways
Lijun Tao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Kelly L. Walton et al.
FRONTIERS IN PHARMACOLOGY (2017)
Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis
Keith C. Meyer
EXPERT REVIEW OF RESPIRATORY MEDICINE (2017)
Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways
Shu-Hong Dong et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Molecular mechanisms regulating NLRP3 inflammasome activation
Eun-Kyeong Jo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung
Ismini Lasithiotaki et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation
Wen Liu et al.
ONCOTARGET (2016)
Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis?
Sabah Ahmed et al.
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS (2016)
Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α, and IL-1β
Amit D. Kandhare et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Effects of sphingosylphosphorylcholine against oxidative stress and acute lung injury induced by pulmonary contusion in rats
Burhan Aksu et al.
JOURNAL OF PEDIATRIC SURGERY (2015)
Nintedanib in the treatment of idiopathic pulmonary fibrosis
Mariano E. Mazzei et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2015)
Synergistic Effect of Bolus Exposure to Zinc Oxide Nanoparticles on Bleomycin-Induced Secretion of Pro-Fibrotic Cytokines without Lasting Fibrotic Changes in Murine Lungs
Wenting Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis
Ellen De langhe et al.
RESPIRATORY RESEARCH (2015)
Toll-Like Receptor 4 Signaling Augments Transforming Growth Factor-β Responses A Novel Mechanism for Maintaining and Amplifying Fibrosis in Scleroderma
Swati Bhattacharyya et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments
Moritz Haneklaus et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Bleomycin Induces Molecular Changes Directly Relevant to Idiopathic Pulmonary Fibrosis: A Model for Active Disease
Ruoqi Peng et al.
PLOS ONE (2013)
Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway
Haitao Shi et al.
TOXICOLOGY (2013)
TLR4 Activity Is Required in the Resolution of Pulmonary Inflammation and Fibrosis after Acute and Chronic Lung Injury
Hong-Zhen Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodelling
Jian Gao et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
Pirfenidone in idiopathic pulmonary fibrosis
H. Taniguchi et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Promising pharmacologic innovations in treating pulmonary fibrosis
Nitin Bhatt et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells
A Tsung et al.
JOURNAL OF IMMUNOLOGY (2005)
Regulation of lung injury and repair by Toll-like receptors and hyaluronan
DH Jiang et al.
NATURE MEDICINE (2005)
分享论文
